STM publisher Elsevier has announced the publication of the latest edition of Knobil and Neill's Physiology of Reproduction. Elsevier is introducing this updated foundational reference on human and comparative reproduction along with eight other life sciences book titles at the Experimental Biology 2015 conference held in Boston from March 28–April 1, 2015. The new books are part of Elsevier's life sciences book portfolio and will be on display at booth # 542.
The new edition of the two-volume set, Knobil and Neill's Physiology of Reproduction, edited by Dr. Tony M. Plant and Dr. Anthony J. Zeleznik, has been extensively revised, reflecting numerous fundamental advancements in this rapidly developing field. It provides a common language for researchers across the fields of physiology, endocrinology and biology to discuss their understanding of reproduction. The new edition synthesizes all of this new information at the molecular, cellular and organismal levels of organization and presents modern physiology in a more understandable and comparative context.
Dr. Plant's research has been focused on the neurobiology of puberty onset, the neuroendocrine control of the menstrual cycle and testis, the endocrine control of spermatogenesis and, most recently, in the cell and molecular biology underlying spermatogonial differentiation. Dr. Zeleznik's doctoral work was the first to document that a principal action of follicle stimulating hormone in the ovary was to induce LH receptors on granulosa cells, an action that enables the follicle to ovulate and luteinize in response to LH.
The nine new life sciences books are: Knobil and Neill's Physiology of Reproduction, Fourth Edition by Tony Plant and Anthony Zeleznik; Genomic Control Process: Development and Evolution by Isabelle Peter and Eric Davidson; MicroRNA in Regenerative Medicine by Chandan Sen; Heat Transfer and Fluid Flow in Biological Processes by Sid Becker and Andrey Kuznetsov; Re-Engineering Clinical Trials: Best Practices for Streamlining the Development Process by Peter Schueler and Brendan Buckley; Introductory Experiments on Biomolecules and Their Interactions by Robert DeLong and Qiongqiong Zhou; Hematology and Coagulation: A Comprehensive Review for Board Preparation, Certification and Clinical Practice by Amer Wahed and Amitava Dasgupta; MRI Atlas of Pituitary Pathology by Kevin Pantalone, Stephen Jones, Robert Weil and Amir Hamrahian; and Planning a Career in Biomedical and Life Sciences: Making Informed Choices by Avrum Gotlieb.
The books are available on the Elsevier Store and on ScienceDirect, Elsevier's full-text scientific database offering journal articles and book chapters from over 2,500 peer-reviewed journals and more than 33,000 book titles.
At the conference, Elsevier is also launching EBioMedicine, an open-access journal supported by Cell Press and The Lancet. The scope of EBioMedicine will cover the entire breadth of translational and clinical research within all disciplines of life and health sciences, ranging from basic science to clinical and public/global health science. The journal will also place a high priority on rapid publication.
Publisher John Wiley & Sons, Inc. has announced the launch of a new open access journal spanning the entire breadth of the dentistry field, Clinical and Experimental Dental Research (CEDR).
CEDR will publish quality, peer-reviewed articles on all aspects of dentistry and oral surgery, diseases, and medicine. This provides authors with a new platform for rapid publication and dissemination of their research in the dental field.
The journal joins Wiley's portfolio of dentistry journals as one of the first open access journals to provide extensive coverage of the dentistry field. CEDR is supported by many respected titles including the Journal of Clinical Periodontology, Clinical Oral Implants Research and Molecular Oral Microbiology.
Dr. Asbjørn Jokstad, professor at The Arctic University of Norway in Tromsø, Norway, will serve as the Editor-in-Chief of CEDR. Dr. Jokstad has produced numerous research and teaching publications, book chapters and conference presentations in multiple fields of dentistry, with special emphasis on evidence-based dentistry, conservative dentistry, prosthodontics, toxicology and on TMD.
All articles in CEDR will be published under the Creative Commons Attribution (CC-BY) License on Wiley Online Library. Authors with open access mandates from funders will be fully compliant when publishing with this journal. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organisation that has a Wiley Open Access Account can publish without directly paying any publication charges.
The journal is open to submissions now and will publish online in spring 2015.
The CLOCKSS Archive, a not-for-profit joint venture between the world's leading academic publishers and research libraries, has entered into an agreement with CHORUS (Clearinghouse for the Open Research of the United States), the not-for-profit, cost-effective, and sustainable public access solution, to support the archiving, preservation, and perpetual public access to articles reporting on US federally funded research, at no additional cost to taxpayers.
As a result of the agreement, CHORUS Publisher Members will be able to take advantage of a special arrangement with CLOCKSS to establish permanent, perpetual public access to content and ensure the integrity and sustainability of the scholarly record. CHORUS works with US federal agencies, publishers, service providers, and researchers to enable, monitor, and preserve public access to published articles. Built on CrossRef's open, interoperable framework, CHORUS services are initiated when researchers submit their articles to publishers.
CLOCKSS has agreements with 200 publishers and has preserved more than 11,000 academic journals, from participating scientific publishers. Through the agreement, CLOCKSS will provide public access to the archived publications should a publisher fail to provide public access for a period of longer than 30 days and there no other parties providing public access.
PennWell Corporation, a diversified global media and information company, has announced that it will publish Oil, Gas & Petrochem Equipment (OG&PE) as part of its Oil & Gas Journal beginning in May to serve a consolidated audience of 137,000 oil and gas professionals worldwide.
OG&PE grew out of Oil & Gas Journal in 1954 and has since been published monthly to cover industry equipment. Oil & Gas Journal, known as the industry's leading weekly international news and technology magazine, began life in 1902 to focus on upstream, midstream, and downstream operations. While leaving both brands intact, the reunion combines Oil & Gas Journal's news, technology, and statistics with OG&PE's coverage of equipment and services.
The product-rich OGPE.com website and weekly Equip-Alert e-Newsletter will continue in their present formats, with daily postings and social media. Oil & Gas Journal retains its weekly frequency, with OG&PE to be included in its printed issue the first week of each month. Oil & Gas Journal also publishes weekly in a digital magazine format, along with its full suite of digital services, including OGJ.com, multiple newsletters, and social media.
Based in Tulsa, veteran editor J.B. Avants will continue to lead OG&PE in collaboration with Oil & Gas Journal editor Bob Tippee.
Publisher Mary Ann Liebert, Inc., publishers has announced the appointment of Dr. Terry R. Flotte, Executive Deputy Chancellor, Provost, and Dean of the School of Medicine at University of Massachusetts Medical School, as the new incoming Editor-in-Chief of Human Gene Therapy, Human Gene Therapy Methods, and Human Gene Therapy Clinical Development, effective July 1, 2015. Dr. Flotte is currently an Associate Editor of the Journal.
Dr. Flotte will succeed Dr. James M. Wilson, Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, who has been Editor-in-Chief of the Journal since 2003.
Dr. Flotte is well known in the gene therapy community. He was the Principal Investigator for the first use of rAAV in humans, in cystic fibrosis trials beginning in 1995, leading to important early safety data and contributing important observations regarding molecular mechanisms of rAAV persistence and immune responses in humans. Dr. Flotte is the author of more than 230 scholarly papers, his published work has been cited close to 7,500 times, and his research has been continuously NIH funded for 22 years. The Flotte lab is currently investigating the delivery of therapeutic genes and microRNA with recombinant vectors for genetic diseases, such as alpha-1 antitrypsin (AAT) deficiency. Dr. Flotte serves on the Liaison Committee on Medical Education and the ASGCT Advisory Council, setting policy and goals for promoting gene therapy research through public education, scientific meetings, and scientific committees.
Alongside his leadership roles, Dr. Flotte has also continued his pediatric practice while pursuing clinical trials and basic laboratory research. Dr. Flotte has received numerous honors and awards, including the E. Mead Johnson award for outstanding scientific contributions from the Society of Pediatric Research in 2005, the Massachusetts Society for Medical Research Award for pioneering work in human gene therapy and his leadership in groundbreaking biomedical research in 2012. In 2013, he was inducted into the Johns Hopkins Society of Scholars.
The editorial transition will begin on May 1, 2015 and Dr. Flotte will take full helm of the Journal on July 1, 2015.
If you’re producing content for the web and want readers to find your products, you need to understand how to make search optimization work for you. This course focuses on the practical things you can do, explains how search engines work, and equips you with the tools to apply all you have learnt immediately.
This course is run in collaboration with Marketability.
Event Date: December 2, 2015
Projects are fundamental to all publishing organizations. Everyone gets involved in them.They may involve developing new products, new processes and systems, adopting new technologies, reaching new markets, acquiring new business, selecting new suppliers or improving existing processes. Projects are also challenging and often fail to achieve the desired results. This course provides a template and many supporting tools that can be applied to all projects, large or small, to help ensure successful outcomes. It has a strong emphasis on getting things right at the outset because thi s is where most problems with projects arise. The programme is highly practical and includes break-out sessions using real project scenarios provided by delegates as well as providing publishing case studies as examples of what works and what doesn''t.
Event Date: November 24, 2015
A wide range of ethical issues can arise in academic publishing. These can be caused by misbehaving authors (e.g. committing plagiarism or fraud), by abuse of editorial positions and also by conflicts between publishers’ and societies’ commercial interests and principles of editorial freedom and integrity. This course will cover how to effectively detect and deal with possible misconduct and show the importance of having sound ethical policies. While the principles and theories covered are applicable across most publication types, some issues covered will be particularly relevant to journals publishing.
Event Date: November 17, 2015
This course will provide an insight into the technologies behind eJournal delivery. Technology has removed the barriers between production, editorial, marketing, sales, customer services and most importantly – the customers. The course will be business-centric – clearly positioning technologies in the context of the industry issues they aim to solve. Participants will learn how technology is used throughout the delivery of eJournals from publisher via library to the end-user.
Event Date: November 12, 2015
This course has been designed as a follow-on from Journal Development 1 which provides participants with a toolbox system for planning the development of their journals. This more advanced course looks at overarching strategies for journal development including acquisition and portfolio development. The course is built around case studies to allow participants to work on simulated scenarios in order to discuss and test ideas and strategies with their peers and the course facilitators.
Event Date: November 10, 2015
The US Center for Science in the Public Interest has questioned medical journals for not revealing the financial relationship the authors hold with drug companies for the studies that may potentially benefit the companies. . Scientists whose researches are funded by drug companies often publish their reports in prestigious scientific journals. Drug companies who fund the reports claim the results of the study while marketing the product. Publishers of the journals are left clueless about the funding agreement. Click Here
Allen Press had conducted an annual study to identify the pricing patterns of scientific and medical journals. The research covers the 2004 pricing of US journals and gives recommendations on the pricing structure for 2005. It carries comparisons between the pricing structures of non-profit society journals and discusses general pricing trends in the US. The author also ranks the journals based on the subscription charges and science categories with higher prices. The paper also forecasts the pricing strategy of science journals in 2005. Click Here
Researchers have voiced their support to Open Access (OA) that makes their works available to anyone free of cost. While commercial publishers have given a subdued response to OA, scientists welcome OA archiving, wherein institutions or academics maintain an electronic format of the studies submitted by the scientists. Amidst disapproval from publishers and scientific groups, OA archiving is gaining acceptance from developed nations. Economic factors, existing subsidised but limited free content supported by publishers and an inclination to traditional publishing are a few reasons that impede support for OA archiving from developing countries. Click Here
The “open access movement”, which is rapidly gaining ground in the area of STM publishing, stresses the free use of online medical research. As commercial publishers set high prices for medical periodicals and libraries struggle to sustain amidst shrinking budgets, a debate has flared up on the need for open access. Clinical and basic researchers point out that as these studies are funded by the government, the publishers must make them available for free. The increasing use of electronic format of journals has induced independent publishers, such as ASCO and JCO, to host e-journals as an extension of their respective membership programmes and educational missions. Click Here
The open access movement is gaining momentum. Critics have voiced their strong protests against the pricing of STM journals. The spiralling prices were, in fact, the major reason for the launch and rapid spreading of the open access movement. Does this mean the end of SRM publishers? No, says Bill Town in his article in Computing. Click Here
270 Madison Avenue,New York ,NY-10016-0602website
40 Salem Street,Lynnfield,MA-01940website
3501 Market Street,Philadelphia,PA-19104website
333 Seventh Avenue, 20th floor,New York ,NY -10001website
Chemical Abstracts Service
2540 Olentangy River Road, ,PO Box 3012, Columbus,OH-43210website